152 related articles for article (PubMed ID: 2416269)
21. Progressive supranuclear palsy.
Duvoisin RC; Golbe LI; Lepore FE
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):547-54. PubMed ID: 3315157
[TBL] [Abstract][Full Text] [Related]
22. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss.
Kish SJ; Rajput A; Gilbert J; Rozdilsky B; Chang LJ; Shannak K; Hornykiewicz O
Ann Neurol; 1986 Jul; 20(1):26-31. PubMed ID: 2874765
[TBL] [Abstract][Full Text] [Related]
23. Aging and neurotransmitter systems.
McGeer EG; McGeer PL
Adv Biochem Psychopharmacol; 1980; 23():305-14. PubMed ID: 6104910
[No Abstract] [Full Text] [Related]
24. Development of tolerance to benzodiazepines. I. Changes in the systems of central nervous system neurotransmitters during long-term administration of nitrazepam.
Nowakowska E; Chodera A; Szczawińska K; Cenajek D
Acta Physiol Pol; 1983; 34(3):345-51. PubMed ID: 6202092
[TBL] [Abstract][Full Text] [Related]
25. The ageing brain and dementia--a review.
Davison AN
Br J Clin Pract Suppl; 1985 Jun; 39():3-6. PubMed ID: 2864054
[No Abstract] [Full Text] [Related]
26. Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.
Arai H; Ichimiya Y; Kosaka K; Moroji T; Iizuka R
Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):883-90. PubMed ID: 1381103
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a role of neurotransmitters in the mechanism of topical convulsant models.
Craig CR
Fed Proc; 1984 Jul; 43(10):2525-8. PubMed ID: 6145629
[TBL] [Abstract][Full Text] [Related]
28. [Ageing and neurotransmitters].
Nakamura S; Miyata S
Nihon Naika Gakkai Zasshi; 1985 Oct; 74(10):1348-52. PubMed ID: 2869092
[No Abstract] [Full Text] [Related]
29. Dopamine systems in human immunodeficiency virus-associated dementia.
Lopez OL; Smith G; Meltzer CC; Becker JT
Neuropsychiatry Neuropsychol Behav Neurol; 1999 Jul; 12(3):184-92. PubMed ID: 10456803
[TBL] [Abstract][Full Text] [Related]
30. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
Winter C; Djodari-Irani A; Sohr R; Morgenstern R; Feldon J; Juckel G; Meyer U
Int J Neuropsychopharmacol; 2009 May; 12(4):513-24. PubMed ID: 18752727
[TBL] [Abstract][Full Text] [Related]
31. Influence of supidimide on brain neurotransmitter systems of rats and mice.
Hennies HH; Günzler WA; Flohé L
Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
[TBL] [Abstract][Full Text] [Related]
32. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
Liepelt I; Maetzler W; Blaicher HP; Gasser T; Berg D
Dement Geriatr Cogn Disord; 2007; 23(6):351-67. PubMed ID: 17389795
[TBL] [Abstract][Full Text] [Related]
33. Discrete regional distribution of biochemical markers for the dopamine, noradrenaline, serotonin, GABA and acetylcholine systems in the monkey brain (Cebus Apella). Effects of stress.
Häggström JE; Sjöquist B; Eckernäs SA; Ingvast A; Gunne LM
Acta Physiol Scand Suppl; 1984; 534():1-27. PubMed ID: 6150601
[TBL] [Abstract][Full Text] [Related]
34. Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA.
Vihavainen T; Relander TR; Leiviskä R; Airavaara M; Tuominen RK; Ahtee L; Piepponen TP
J Neurochem; 2008 Nov; 107(3):844-54. PubMed ID: 18786163
[TBL] [Abstract][Full Text] [Related]
35. [Modifications in neurotransmission in degenerative dementia].
Maloteaux JM
Acta Neurol Belg; 1989; 89(3-4):186-93. PubMed ID: 2576495
[No Abstract] [Full Text] [Related]
36. A case of frontotemporal dementia and parkinsonism of early onset with progressive supranuclear palsy-like features.
Miyamoto K; Ikemoto A; Akiguchi I; Kohno R; Imura T; Fujita Y
Clin Neuropathol; 2001; 20(1):8-12. PubMed ID: 11220696
[TBL] [Abstract][Full Text] [Related]
37. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
38. Neurochemical correlates to selective neuronal vulnerability.
Wieloch T
Prog Brain Res; 1985; 63():69-85. PubMed ID: 2872696
[No Abstract] [Full Text] [Related]
39. Biochemical interactions in the basal ganglia.
McGeer PL; McGeer EG; Hattori T
Prog Brain Res; 1979; 51():285-301. PubMed ID: 95234
[No Abstract] [Full Text] [Related]
40. Basal ganglia neurotransmitter concentrations in rhesus monkeys following subchronic manganese sulfate inhalation.
Struve MF; McManus BE; Wong BA; Dorman DC
Am J Ind Med; 2007 Oct; 50(10):772-8. PubMed ID: 17620281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
